JP2008515586A - 前立腺治療ステント - Google Patents
前立腺治療ステント Download PDFInfo
- Publication number
- JP2008515586A JP2008515586A JP2007536347A JP2007536347A JP2008515586A JP 2008515586 A JP2008515586 A JP 2008515586A JP 2007536347 A JP2007536347 A JP 2007536347A JP 2007536347 A JP2007536347 A JP 2007536347A JP 2008515586 A JP2008515586 A JP 2008515586A
- Authority
- JP
- Japan
- Prior art keywords
- implant
- tissue
- urethra
- optionally
- coil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002307 prostate Anatomy 0.000 title description 45
- 239000007943 implant Substances 0.000 claims abstract description 711
- 238000000034 method Methods 0.000 claims abstract description 87
- 238000003825 pressing Methods 0.000 claims abstract description 15
- 201000001988 urethral stricture Diseases 0.000 claims abstract description 13
- 206010065584 Urethral stenosis Diseases 0.000 claims abstract description 11
- 210000001519 tissue Anatomy 0.000 claims description 208
- 210000003708 urethra Anatomy 0.000 claims description 99
- 239000000463 material Substances 0.000 claims description 77
- 238000003780 insertion Methods 0.000 claims description 47
- 230000037431 insertion Effects 0.000 claims description 47
- 230000002966 stenotic effect Effects 0.000 claims description 35
- 230000000975 bioactive effect Effects 0.000 claims description 32
- 238000002679 ablation Methods 0.000 claims description 25
- 238000004804 winding Methods 0.000 claims description 25
- 210000005070 sphincter Anatomy 0.000 claims description 23
- 238000002271 resection Methods 0.000 claims description 17
- 239000000523 sample Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 230000008602 contraction Effects 0.000 claims description 10
- 210000003205 muscle Anatomy 0.000 claims description 9
- 230000001338 necrotic effect Effects 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000013307 optical fiber Substances 0.000 claims description 7
- 230000008467 tissue growth Effects 0.000 claims description 6
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 230000017074 necrotic cell death Effects 0.000 claims description 5
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 229960005475 antiinfective agent Drugs 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 238000007674 radiofrequency ablation Methods 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000000576 coating method Methods 0.000 description 20
- 239000011248 coating agent Substances 0.000 description 19
- 230000037361 pathway Effects 0.000 description 16
- 210000002700 urine Anatomy 0.000 description 12
- 230000001681 protective effect Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 7
- 229910001000 nickel titanium Inorganic materials 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 5
- 238000004873 anchoring Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000007634 remodeling Methods 0.000 description 5
- 206010028851 Necrosis Diseases 0.000 description 4
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000012781 shape memory material Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000012966 insertion method Methods 0.000 description 3
- 201000004240 prostatic hypertrophy Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 206010017711 Gangrene Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010051482 Prostatomegaly Diseases 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- JUGUHFNYFLSPAJ-VEDVMXKPSA-N C[C@H]1C(CC=C)CCC1 Chemical compound C[C@H]1C(CC=C)CCC1 JUGUHFNYFLSPAJ-VEDVMXKPSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 229920000271 Kevlar® Polymers 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000010317 ablation therapy Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229920006238 degradable plastic Polymers 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002654 heat shrinkable material Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000010329 laser etching Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229920000431 shape-memory polymer Polymers 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00274—Prostate operation, e.g. prostatectomy, turp, bhp treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B2017/32096—Incision instruments for slowly cutting through tissue, e.g. stent like temporary implants having sharp edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00547—Prostate
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL16456304A IL164563A0 (en) | 2004-10-13 | 2004-10-13 | Prostate treatment stent |
| PCT/IL2005/001080 WO2006040767A1 (en) | 2004-10-13 | 2005-10-11 | Prostate treatment stent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008515586A true JP2008515586A (ja) | 2008-05-15 |
| JP2008515586A5 JP2008515586A5 (enExample) | 2008-10-30 |
Family
ID=35610228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536347A Pending JP2008515586A (ja) | 2004-10-13 | 2005-10-11 | 前立腺治療ステント |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20060095058A1 (enExample) |
| EP (1) | EP1819299A1 (enExample) |
| JP (1) | JP2008515586A (enExample) |
| AU (1) | AU2005293150A1 (enExample) |
| CA (1) | CA2584509A1 (enExample) |
| IL (2) | IL164563A0 (enExample) |
| WO (1) | WO2006040767A1 (enExample) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010252967A (ja) * | 2009-04-23 | 2010-11-11 | Kunio Kasugai | 内視鏡用穿刺針 |
| WO2012073774A1 (ja) * | 2010-12-02 | 2012-06-07 | 国立大学法人高知大学 | 近赤外蛍光を発する医療具及び医療具位置確認システム |
| WO2013180127A1 (ja) | 2012-06-01 | 2013-12-05 | 国立大学法人高知大学 | 近赤外蛍光を発する医療品、および医療品の使用状況確認装置 |
| US10349886B2 (en) | 2012-05-29 | 2019-07-16 | National University Corporation Kochi University | Artery visualization device and artery imaging device |
| KR20200005735A (ko) * | 2017-05-05 | 2020-01-16 | 프로데온, 인코포레이티드 | 양성 전립선 비대증(bph) 및 관련 하부 요로 증상(luts)을 치료하기 위한 이식 가능한 디바이스 및 방법 |
| JP2020528790A (ja) * | 2017-07-28 | 2020-10-01 | ゼンフロー, インコーポレイテッド | 尿道前立腺部の直径を拡張するためのシステム、デバイス、および方法 |
| JP2023087678A (ja) * | 2021-12-13 | 2023-06-23 | オリンパス・ウィンター・アンド・イベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インプラントおよび手持ち式の医療デバイス |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351421B2 (en) * | 1996-11-05 | 2008-04-01 | Hsing-Wen Sung | Drug-eluting stent having collagen drug carrier chemically treated with genipin |
| US7766899B2 (en) * | 2003-09-17 | 2010-08-03 | Prostalund Operations Ab | Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots |
| US7004965B2 (en) * | 2003-12-17 | 2006-02-28 | Yosef Gross | Implant and delivery tool therefor |
| US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
| US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
| US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
| US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
| US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
| GB0621048D0 (en) * | 2006-10-23 | 2006-11-29 | Anson Medical Ltd | Helical stent graft |
| US20080208214A1 (en) * | 2007-02-26 | 2008-08-28 | Olympus Medical Systems Corp. | Applicator and tissue fastening method through natural orifice |
| US8603187B2 (en) | 2007-05-07 | 2013-12-10 | Medi-Tate | Device for dilating the urethra of the body of a patient and device for removing prostate tissue |
| US20100130815A1 (en) * | 2007-05-18 | 2010-05-27 | Prostaplant Ltd. | Intraurethral and extraurethral apparatus |
| US9848905B2 (en) | 2008-12-22 | 2017-12-26 | Medi-Tate Ltd. | Radial cutter implant |
| EP2408506B1 (en) * | 2009-03-20 | 2020-09-16 | Proarc Medical Ltd. | Devices for urethral treatment |
| US20130204311A1 (en) * | 2010-05-12 | 2013-08-08 | Helical Solutions, Inc. | Implants and methods for treating cardiac arrhythmias |
| US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
| US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
| US20140163586A1 (en) * | 2012-12-11 | 2014-06-12 | Dolly Jeanne Holt | Tissue repair devices and methods |
| US20160000455A1 (en) | 2013-03-14 | 2016-01-07 | Proarc Medical Ltd. | Methods and devices for urethral treatment |
| DK3089780T3 (da) | 2013-12-30 | 2019-12-09 | Medi Tate Ltd | Indsnitsimplantat for prostata-urinrør |
| CA3046087A1 (en) | 2016-12-09 | 2018-06-14 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
| AU2018389236B2 (en) | 2017-12-23 | 2021-05-20 | Teleflex Life Sciences Llc | Expandable tissue engagement apparatus and method |
| ES3027332T3 (en) | 2018-03-19 | 2025-06-13 | Medi Tate Ltd | Urethral implant delivery system |
| CN112384169A (zh) * | 2018-05-17 | 2021-02-19 | 真复灵公司 | 用于使植入物在前列腺尿道中正确展开和成像的系统、装置和方法 |
| WO2020008455A1 (en) | 2018-07-01 | 2020-01-09 | Medi-Tate Ltd. | Urethral implant |
| US12440301B2 (en) | 2018-11-07 | 2025-10-14 | Teleflex Life Sciences Llc | System for delivery of a fiducial marker |
| AU2020387396B2 (en) | 2019-11-19 | 2025-10-30 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra |
| JP2025123184A (ja) | 2024-02-12 | 2025-08-22 | メディ-テイト リミテッド | 前立腺尿道インプラント |
| EP4663168A1 (en) | 2024-06-13 | 2025-12-17 | Medi-Tate Ltd. | Stent device with extension for treating bladder neck |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05507633A (ja) * | 1990-04-19 | 1993-11-04 | インステント インコーポレイテッド | 圧迫された管の治療のための装置 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100423A (en) * | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
| US5372600A (en) * | 1991-10-31 | 1994-12-13 | Instent Inc. | Stent delivery systems |
| US6090115A (en) * | 1995-06-07 | 2000-07-18 | Intratherapeutics, Inc. | Temporary stent system |
| US5503635A (en) * | 1993-11-12 | 1996-04-02 | United States Surgical Corporation | Apparatus and method for performing compressional anastomoses |
| FR2722413B1 (fr) * | 1994-07-13 | 1997-02-07 | Marian Devonec | Implant therapeutique destine au traitement cytoreducteur selectif de l'obstruction d'une lumiere ou voie naturelle d'un corps humain ou animal |
| US5601591A (en) * | 1994-09-23 | 1997-02-11 | Vidamed, Inc. | Stent for use in prostatic urethra, apparatus and placement device for same and method |
| EP0794726A4 (en) * | 1994-10-20 | 1998-01-07 | Instent Inc | CYTOSCOPIC SYSTEM FOR IMPLANTATION OF AN EXTENDER |
| US5588965A (en) * | 1995-03-07 | 1996-12-31 | American Medical Systems, Inc. | Device for slowly dilating the prostatic urethra |
| EP0932426A4 (en) * | 1996-02-02 | 2003-07-30 | Transvascular Inc | METHOD AND DEVICE FOR CONNECTING OPENINGS IN NEIGHBORHOOD BLOOD VESSELS OR IN OTHER ANATOMIC STRUCTURES |
| US6702846B2 (en) * | 1996-04-09 | 2004-03-09 | Endocare, Inc. | Urological stent therapy system and method |
| US5830179A (en) * | 1996-04-09 | 1998-11-03 | Endocare, Inc. | Urological stent therapy system and method |
| US6077257A (en) * | 1996-05-06 | 2000-06-20 | Vidacare, Inc. | Ablation of rectal and other internal body structures |
| DE69928224T2 (de) * | 1998-01-26 | 2006-08-03 | Anson Medical Ltd., Didcot | Verstärktes implantat |
| US6440127B2 (en) * | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
| US6083237A (en) * | 1998-10-23 | 2000-07-04 | Ethico Endo-Surgery, Inc. | Biopsy instrument with tissue penetrating spiral |
| WO2001058368A1 (en) * | 2000-02-10 | 2001-08-16 | Harmonia Medical Technologies Inc. | Transurethral volume reduction of the prostate (tuvor) |
| US6460542B1 (en) * | 2001-01-03 | 2002-10-08 | Medical Technology & Innovations, Inc. | Female incontinence control device |
| US6733536B1 (en) * | 2002-10-22 | 2004-05-11 | Scimed Life Systems | Male urethral stent device |
-
2004
- 2004-10-13 IL IL16456304A patent/IL164563A0/xx active IP Right Grant
-
2005
- 2005-10-11 WO PCT/IL2005/001080 patent/WO2006040767A1/en not_active Ceased
- 2005-10-11 AU AU2005293150A patent/AU2005293150A1/en not_active Abandoned
- 2005-10-11 CA CA002584509A patent/CA2584509A1/en not_active Abandoned
- 2005-10-11 JP JP2007536347A patent/JP2008515586A/ja active Pending
- 2005-10-11 EP EP05796106A patent/EP1819299A1/en not_active Withdrawn
- 2005-10-12 US US11/248,733 patent/US20060095058A1/en not_active Abandoned
-
2007
- 2007-04-12 IL IL182533A patent/IL182533A/en active IP Right Grant
-
2010
- 2010-12-06 US US12/961,120 patent/US20110077676A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05507633A (ja) * | 1990-04-19 | 1993-11-04 | インステント インコーポレイテッド | 圧迫された管の治療のための装置 |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010252967A (ja) * | 2009-04-23 | 2010-11-11 | Kunio Kasugai | 内視鏡用穿刺針 |
| WO2012073774A1 (ja) * | 2010-12-02 | 2012-06-07 | 国立大学法人高知大学 | 近赤外蛍光を発する医療具及び医療具位置確認システム |
| JP2012115535A (ja) * | 2010-12-02 | 2012-06-21 | Kochi Univ | 近赤外蛍光を発する医療具及び医療具位置確認システム |
| US10349886B2 (en) | 2012-05-29 | 2019-07-16 | National University Corporation Kochi University | Artery visualization device and artery imaging device |
| US11179058B2 (en) | 2012-06-01 | 2021-11-23 | National University Corporation Kochi University | Medical product emitting near-infrared fluorescence and medical product usage status checking apparatus |
| WO2013180127A1 (ja) | 2012-06-01 | 2013-12-05 | 国立大学法人高知大学 | 近赤外蛍光を発する医療品、および医療品の使用状況確認装置 |
| KR20200005735A (ko) * | 2017-05-05 | 2020-01-16 | 프로데온, 인코포레이티드 | 양성 전립선 비대증(bph) 및 관련 하부 요로 증상(luts)을 치료하기 위한 이식 가능한 디바이스 및 방법 |
| CN110799237A (zh) * | 2017-05-05 | 2020-02-14 | 意能生技股份有限公司 | 治疗良性前列腺增生(bph)和相关的下尿路症状(luts)的可植入装置及方法 |
| JP2020518384A (ja) * | 2017-05-05 | 2020-06-25 | プロデオン・インコーポレイテッドProdeon, Inc. | 良性前立腺肥大症(bph)および関連する下部尿路症状(luts)を治療するための植え込み可能なデバイスおよび方法 |
| US11497637B2 (en) | 2017-05-05 | 2022-11-15 | Prodeon Medical Corporation | Implantable devices and methods to treat benign prostate hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) |
| KR102487146B1 (ko) * | 2017-05-05 | 2023-01-12 | 프로데온 메디칼 코포레이션 | 양성 전립선 비대증(bph) 및 하부 요로 증상(luts)을 치료하기 위한 임플란트 |
| JP2023030178A (ja) * | 2017-05-05 | 2023-03-07 | プロデオン・メディカル・コーポレイション | 良性前立腺肥大症(bph)および関連する下部尿路症状(luts)を治療するための植え込み可能なデバイスおよび方法 |
| JP7508538B2 (ja) | 2017-05-05 | 2024-07-01 | プロデオン・メディカル・コーポレイション | 良性前立腺肥大症(bph)および関連する下部尿路症状(luts)を治療するための植え込み可能なデバイスおよび方法 |
| JP2020528790A (ja) * | 2017-07-28 | 2020-10-01 | ゼンフロー, インコーポレイテッド | 尿道前立腺部の直径を拡張するためのシステム、デバイス、および方法 |
| JP2023087678A (ja) * | 2021-12-13 | 2023-06-23 | オリンパス・ウィンター・アンド・イベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インプラントおよび手持ち式の医療デバイス |
Also Published As
| Publication number | Publication date |
|---|---|
| IL182533A (en) | 2011-03-31 |
| US20060095058A1 (en) | 2006-05-04 |
| EP1819299A1 (en) | 2007-08-22 |
| CA2584509A1 (en) | 2006-04-20 |
| IL182533A0 (en) | 2007-09-20 |
| US20110077676A1 (en) | 2011-03-31 |
| IL164563A0 (en) | 2005-12-18 |
| WO2006040767A1 (en) | 2006-04-20 |
| AU2005293150A1 (en) | 2006-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515586A (ja) | 前立腺治療ステント | |
| US12268411B2 (en) | Radial cutter implant | |
| US11497637B2 (en) | Implantable devices and methods to treat benign prostate hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) | |
| JP6130627B2 (ja) | 組織又は解剖学的構造の牽引、持ち上げ、圧縮、支持、又は復位を行うためのデバイス、システム、及び方法 | |
| JP2024114950A (ja) | 組織を後退させる為の装置および方法 | |
| WO2004073556A1 (en) | Stent | |
| CN114305602A (zh) | 用于尿道前列腺部的切割植入物 | |
| US20210307942A1 (en) | Intraluminal devices for treating benign prostatic hyperplasia | |
| US20250381022A1 (en) | Urethral treatment apparatus and method | |
| US20240108868A1 (en) | Implant | |
| CN101330877A (zh) | 用于使分别限定两个体腔的组织吻合的器械 | |
| TW202504564A (zh) | 可收回的植入物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20080813 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080827 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080827 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080813 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110301 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110816 |